ART4 and Alzheimer disease: The modification of MSC-derived EVs (RVG-EVs) with CNS-specific rabies virus glycoprotein (RVG) peptides, based on the aforementioned principle, resulted in improved targeting of EVs to the Alzheimer’s disease (AD) mouse cortex and hippocampus.